학술논문

Priming with a simplified intradermal HIV-1 DNA vaccine regimen followed by boosting with recombinant HIV-1 MVA vaccine is safe and immunogenic: a phase IIa randomized clinical trial
Document Type
Artikel
Source
PloS one. 10(4):e0119629
Subject
Medicin och hälsovetenskap
Language
English
English
ISSN
1932-6203